MedTrace Logo

Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

NCT00717379 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2009-04-15

No results posted yet for this study

Summary

To compare the efficacy and safety of Tacrolimus in combination with MMF and Steroids in two regimens of steroid in an adult kidney transplanted population.

Conditions

  • Kidney Transplantation
  • Kidney Failure, Chronic
  • Renal Insufficiency, Chronic

Interventions

DRUG

Tacrolimus

oral

DRUG

Mycophenolate Mofetil

oral

DRUG

Methylprednisolone or equivalent

oral

DRUG

Prednisone

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Central Contact · ZAO Astellas Pharma Russia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00717379 on ClinicalTrials.gov